Abstract
Enteral nutrition is a widely used technique when nutritional support is proposed for critically ill patients. Complications associated with enteral nutrition are: mechanical, infectious, metabolic, and gastrointestinal. Gastroparesis is the condition that most frequently interferes in the continuity of the nutrition.Additional measures are required for the treatment of patients on enteral nutrition that have gastroparesis, including the use of drugs indicated to increase or restore gastrointestinal motility, and thus improve the peripheral activity of the digestive tract.Gastroparesis is a common condition in critically ill patients that may lead to malnutrition, prolonged hospital stay, and with this, mainly infectious complications. This is why metoclopramide, as a prokinetic and antiemetic agent, is widely used in intensive care units when the critical patient persists with gastroparesis.The objective of the present review is to demonstrate the use, side effects, and doses of metoclopramide and second line adjuvant agents in the treatment of gastroparesis in the intensive care unit.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
